# 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

> **NCT01916148** · — · AVAILABLE · sponsor: **Children's Hospital of Philadelphia**

## Conditions studied

- Congenital Hyperinsulinism (CHI)
- Beckwith-Wiedemann Syndrome
- Insulinoma

## Interventions

- **DRUG:** 18F-DOPA

## Key facts

- **NCT ID:** NCT01916148
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01916148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01916148, "18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01916148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*